House dust mite allergy vaccine(Alk-Abello)

屋尘螨变应原制剂

Report date: 2026/03/17 20:00:15

Base Information

Drug NameHouse dust mite allergy vaccine(Alk-Abello)
Drug Alias NameMites allergens ALK(503) D.p屋尘螨过敏疫苗 - Alk-AbelloAlutard Der pHouse dust mite SCITAlutard +[7] 
ClassificationBiologics > Antigen > Allergen extract
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsConjunctivitisRhinitis, AllergicAsthma
Global Approved IndicationsRhinitis, AllergicAsthma
Approved Indications in ChinaRhinitis, AllergicAsthma
Original Approved Country/TerritoryMainland China
Original Approved Date2004/03/05
Country/TerritoryDenmarkSwitzerlandMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAlk-Abello Sa
China Registration ClassN/A

Develop Information

Active CompaniesAlk-Abello SaUniversity of ZurichAlk-Abelló A/S +[5] 
Inactive CompaniesN/A
Active IndicationsConjunctivitisRhinitis, AllergicAsthma
Inactive IndicationsN/A

Other Information

ATC CodeV01AA03
Related LinksN/A